BridgeBio’s Hub-And-Spoke Model: An Interview With Cameron Turtle

 
• By Joseph Haas
  
BridgeBio lab
A researcher works in the lab of one of BridgeBio's portfolio companies • Source: BridgeBio Pharma Inc.

More from Rare Diseases

More from Scrip